{
  "wikidataId": "Q106629013",
  "name": "Calliditas Therapeutics",
  "description": "Calliditas Therapeutics är ett biopharmaföretag som forskar, utvecklar och kommersialiserar nya terapier för sällsynta sjukdomar. Företagets huvudprodukt, Nefecon, är godkänd för behandling av IgA-nefropati i flera regioner. Calliditas har även en pipeline med NOX-hämmare för inflammatoriska och fibrotiska sjukdomar.",
  "reportingPeriods": [
    {
      "startDate": "2023-01-01T00:00:00.000Z",
      "endDate": "2023-12-31T00:00:00.000Z",
      "reportURL": null,
      "economy": {
        "turnover": {
          "value": 1200000000,
          "currency": "SEK"
        },
        "employees": {
          "value": 181,
          "unit": "Average"
        }
      },
      "emissions": {
        "scope1": null,
        "scope3": {
          "statedTotalEmissions": {
            "total": 0,
            "unit": "tCO2e"
          },
          "categories": [],
          "calculatedTotalEmissions": 0
        },
        "biogenicEmissions": null,
        "scope1And2": null,
        "statedTotalEmissions": null
      }
    },
    {
      "startDate": "2022-01-01T00:00:00.000Z",
      "endDate": "2022-12-31T00:00:00.000Z",
      "reportURL": null,
      "economy": {
        "turnover": {
          "value": 802879000,
          "currency": "SEK"
        },
        "employees": {
          "value": 86,
          "unit": "average number of employees"
        }
      },
      "emissions": {
        "scope1": {
          "total": 15000,
          "unit": "tCO2e"
        },
        "scope2": {
          "lb": 25000,
          "mb": 20000,
          "unknown": 5000,
          "unit": "tCO2e",
          "calculatedTotalEmissions": 20000
        },
        "scope3": {
          "statedTotalEmissions": {
            "total": 0,
            "unit": "tCO2e"
          },
          "categories": [],
          "calculatedTotalEmissions": 0
        },
        "biogenicEmissions": null,
        "scope1And2": null,
        "statedTotalEmissions": null
      }
    },
    {
      "startDate": "2021-01-01T00:00:00.000Z",
      "endDate": "2021-12-31T00:00:00.000Z",
      "reportURL": null,
      "economy": {
        "turnover": {
          "value": 229347000,
          "currency": "SEK"
        },
        "employees": {
          "value": 56,
          "unit": "average number of employees"
        }
      },
      "emissions": {
        "scope1": {
          "total": 14000,
          "unit": "tCO2e"
        },
        "scope2": {
          "lb": 24000,
          "mb": 19000,
          "unknown": 4000,
          "unit": "tCO2e",
          "calculatedTotalEmissions": 19000
        },
        "scope3": {
          "statedTotalEmissions": {
            "total": 0,
            "unit": "tCO2e"
          },
          "categories": [],
          "calculatedTotalEmissions": 0
        },
        "biogenicEmissions": null,
        "scope1And2": null,
        "statedTotalEmissions": null
      }
    },
    {
      "startDate": "2020-01-01T00:00:00.000Z",
      "endDate": "2020-12-31T00:00:00.000Z",
      "reportURL": null,
      "economy": {
        "turnover": {
          "value": 874000,
          "currency": "SEK"
        },
        "employees": {
          "value": 23,
          "unit": "average number of employees"
        }
      },
      "emissions": {}
    },
    {
      "startDate": "2019-01-01T00:00:00.000Z",
      "endDate": "2019-12-31T00:00:00.000Z",
      "reportURL": null,
      "economy": {
        "turnover": {
          "value": 184829000,
          "currency": "SEK"
        },
        "employees": {
          "value": 14,
          "unit": "average number of employees"
        }
      },
      "emissions": {}
    }
  ],
  "industry": {
    "industryGics": {
      "sectorCode": "35",
      "groupCode": "3520",
      "industryCode": "352010",
      "subIndustryCode": "35201010"
    }
  }
}